Immunization Newsbriefs © Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii’s new website at http://www.immunizationinfo.org.
March 13, 2002
“BioPort Working on New Anthrax Vaccine”
BioPort is working on a next-generation anthrax vaccine to stave off potential competition from other companies and groups. The company’s current vaccine is effective, but its 18-month administration time may be too lengthy for mass vaccinations. Only three doses over two months to three months would be necessary for the new nasal spray BioPort is developing. The U.S. military has not made any final determination on restarting mass anthrax immunization among soldiers though the company has fixed its earlier production problem
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.